Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Grows By 2,912.5%

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) was the target of a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 24,100 shares, a growth of 2,912.5% from the October 31st total of 800 shares. Based on an average trading volume of 8,500 shares, the days-to-cover ratio is presently 2.8 days.

NLS Pharmaceutics Price Performance

Shares of NASDAQ:NLSPW traded up $0.00 during trading on Wednesday, hitting $0.01. The company had a trading volume of 10,625 shares, compared to its average volume of 15,836. NLS Pharmaceutics has a one year low of $0.01 and a one year high of $0.17. The company has a fifty day simple moving average of $0.01 and a two-hundred day simple moving average of $0.02.

NLS Pharmaceutics Company Profile

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).